|
Market Closed -
London S.E.
18:35:17 25/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 6.250 GBX | 0.00% |
|
-19.35% | -60.32% |
| 09-22 | EARNINGS and TRADING: Aeorema ups guidance; ZCCM swings to profit | AN |
| 09-22 | SkinBioTherapeutics plc Provides Earnings Guidance for the Fiscal Year 2026 | CI |
| Market Cap | 16.2M 21.45M 18.82M 17.77M 30.32M 2.06B 30.54M 213M 82.38M 1.05B 80.52M 78.78M 3.38B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 19.74M 26.13M 22.93M 21.66M 36.94M 2.5B 37.21M 259M 100M 1.28B 98.11M 95.99M 4.11B | EV / Sales 2026 * |
3.18x | EV / Sales 2027 * | 2.41x |
| Free-Float |
58.8% | Yield 2026 * |
-
| Yield 2027 * | - |
London S.E.GBX
| Markets | Quality | ||
|---|---|---|---|
London S.E.
| SBTX | Delayed | |
Deutsche Boerse AG
| 5KW | Delayed | |
|
Börse Stuttgart
| 5KW | Delayed |
Last Transcript: SkinBioTherapeutics plc
| 1 week | -19.35% | ||
| Current month | -34.21% | ||
| 1 month | -34.21% | ||
| 3 months | -44.44% | ||
| 6 months | -21.88% | ||
| Current year | -60.32% |
| 1 week | 5.5 |  | 8 |
| 1 month | 5.5 | | 10 |
| Current year | 5 | | 23 |
| 1 year | 5 | | 23 |
| 3 years | 5 | | 29.5 |
| 5 years | 5 | | 78.25 |
| 10 years | 5 | | 88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Rachel Parsonage
CEO | Chief Executive Officer | - | 02/03/2026 |
Anita Slater
DFI | Director of Finance/CFO | - | 24/08/2026 |
| Comptroller/Controller/Auditor | - | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/03/2017 | |
Alyson Levett
CHM | Chairman | 60 | - |
Rachel Parsonage
BRD | Director/Board Member | - | 09/03/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/14/23 A | Buy | Chief Executive Officer | 122,517 | 0.0708% | ||
| 4/14/23 A | Sell | Chief Executive Officer | 123,878 | 0.0715% | ||
| 3/9/23 A | Buy | Chief Financial Officer | 86,387 | 0.0499% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -19.35% | -61.54% | -70.59% | 21.45M | |
| -3.30% | +1.50% | +51.24% | +99.26% | 72.26B | |
| +1.25% | -3.01% | +40.12% | +77.12% | 60.24B | |
| +2.12% | +5.26% | +32.50% | +21.28% | 27.73B | |
| -3.06% | -1.81% | -13.10% | +357.06% | 25.74B | |
| -0.75% | +2.56% | +0.45% | -4.46% | 24.75B | |
| +0.40% | +0.75% | +22.91% | -9.68% | 20.74B | |
| -1.70% | -2.12% | +146.86% | +314.52% | 15.06B | |
| +0.36% | -0.34% | +50.32% | +166.42% | 14.42B | |
| +0.21% | +1.17% | -8.07% | +499.10% | 14.23B | |
| Average | -0.45% | -1.54% | +26.17% | +145.00% | 27.52B | |
| Weighted average by Cap. | -0.77% | +0.31% | +36.31% | +129.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.2M 8.21M 7.2M 6.8M 11.61M 787M 11.69M 81.41M 31.53M 402M 30.82M 30.16M 1.29B | 8.2M 10.86M 9.53M 9M 15.35M 1.04B 15.46M 108M 41.71M 532M 40.77M 39.89M 1.71B |
| Net income | - | - |
| Net Debt | 3.54M 4.68M 4.11M 3.88M 6.62M 449M 6.67M 46.46M 17.99M 229M 17.59M 17.21M 737M | 3.57M 4.73M 4.15M 3.92M 6.68M 453M 6.73M 46.89M 18.16M 231M 17.75M 17.37M 744M |
Employees
41
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/09/26 | GBX 6.250 | 0.00% | 188,412 |
| 24/09/26 | GBX 6.250 | +8.70% | 586,245 |
| 23/09/26 | GBX 5.750 | -8.00% | 110,310,966 |
| 22/09/26 | GBX 6.250 | -16.67% | 5,457,159 |
| 21/09/26 | GBX 7.500 | -3.23% | 244,297 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0625GBP
Average target price
0.2900GBP
Spread / Average Target
+364.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SBTX Stock
Select your edition
All financial news and data tailored to specific country editions
